American Funds®

GROWTH & INCOME FUNDS

®

410 Total Holdings:
As of 12/31/14 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 410
Asset Type
Amgen Inc. Equity 20,167,700 $3,212,512,933.00 3.72%
Novartis AG Equity 24,691,054 $2,270,774,116.00 2.63%
Altria Group, Inc. Equity 36,257,500 $1,786,407,025.00 2.07%
Bayer AG Equity 12,312,929 $1,683,293,096.00 1.95%
Gilead Sciences, Inc. Equity 17,384,025 $1,638,618,197.00 1.9%
AbbVie Inc. Equity 20,530,700 $1,343,529,008.00 1.56%
Verizon Communications Inc. Equity 28,449,133 $1,330,850,442.00 1.54%
Philip Morris International Inc. Equity 14,271,100 $1,162,381,095.00 1.35%
BP PLC Equity 182,213,649 $1,157,008,779.00 1.34%
Prudential PLC Equity 49,744,100 $1,144,718,268.00 1.33%
Texas Instruments Inc. Equity 19,056,531 $1,018,857,430.00 1.18%
ASSA ABLOY AB, Class B Equity 15,212,507 $803,933,832.00 0.93%
Oracle Corp. Equity 16,420,000 $738,407,400.00 0.86%
Toyota Motor Corp. Equity 11,871,000 $740,282,292.00 0.86%
UBS Group AG Equity 43,262,786 $743,674,324.00 0.86%
All Holdings: 1 - 15 of 410

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

  1. Excludes certain securities in initial period of acquisition.

Bond ratings, which typically range from AAA/Aaa (highest) to D (lowest), are assigned by credit rating agencies such as Standard & Poor's, Moody's and/or Fitch, as an indication of an issuer's creditworthiness.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.